Striatal Acetylcholine and Behavioral Flexibility

纹状体乙酰胆碱和行为灵活性

基本信息

  • 批准号:
    6749038
  • 负责人:
  • 金额:
    $ 18.27万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-07-01 至 2006-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The main objective of this proposal is to build a greater understanding of how the striatal cholinergic system contributes to behavioral flexibility. There is accumulating evidence that neurological and psychiatric disorders that lead to striatal neuropathology, i.e. Parkinson's disease, Huntington's disease and schizophrenia, produce severe deficits in cognitive flexibility. In addition to the common cognitive symptomology, Parkinson's and Huntington's disease patients both exhibit decreases in cholinergic markers in the anterior regions of the caudate and putamen. At present, unknown is what striatal circuitry or neurochemical mechanisms underlie cognitive flexibility. Advances in elucidating the etiology of these disorders and development of effective treatments for the cognitive deficits relies, in part, on identifying the basic neurochemical mechanisms within the striatum that underlie the cognitive functions impaired in Parkinson's and Huntington's disease. The first goal of the proposal is to understand the dynamic changes in acetylcholine output in the dorsomedial and dorsolateral striatum during acquisition and reversal learning of a visual cue discrimination, using in vivo microdialysis with high pressure liquid chromatography. Recent timings in Parkinson's disease patients suggest that anti-cholinergic treatments lead to cognitive flexibility deficits. The second goal of the proposal is to determine whether specific muscarinic receptor subtypes in the dorsomedial striatum contribute to behavioral flexibility. Previous studies found that dopamine activity in the striatum also influences cognitive flexibility. Furthermore, extant research indicates an interaction between the dopaminergic and cholinergic systems in the basal ganglia related to motor behavior. The third goal of the proposal is to determine whether dopamine D1 and/or D2 receptors modulate acetylcholine efflux in the dorsomedial striatum to influence behavioral flexibility. Overall, this approach takes a unique approach in examining the dynamic changes in striatal acetylcholine release during the actual learning and shifting of strategies. The proposed studies will also provide complimentary information on the specific muscarinic receptors that may facilitate behavioral flexibility in the dorsomedial striatum. Moreover, the proposed studies can help unravel the complex interaction of neurotransmitters in specific striatal circuitry as it relates to behavioral flexibility. The findings from these experiments may enable the development of selective and targeted pharmacological interventions to alleviate the cognitive symptomology in Parkinson's and Huntington's disease without producing unwanted motoric side effects.
描述(由申请人提供):本提案的主要目的是更好地了解纹状体胆碱能系统如何有助于行为灵活性。越来越多的证据表明,导致纹状体神经病理学的神经和精神障碍,即帕金森病、亨廷顿病和精神分裂症,会产生认知灵活性的严重缺陷。除了常见的认知障碍,帕金森病和亨廷顿病患者都表现出尾状核和壳核前部区域的胆碱能标记物减少。目前,认知灵活性背后的纹状体回路或神经化学机制尚不清楚。阐明这些疾病的病因学和开发有效的认知缺陷治疗方法的进展部分依赖于确定纹状体内的基本神经化学机制,这些机制是帕金森病和亨廷顿病中认知功能受损的基础。建议的第一个目标是了解乙酰胆碱输出的动态变化,在背内侧和背外侧纹状体在收购和逆转学习的视觉线索的歧视,在体内微透析与高压液相色谱。最近帕金森病患者的时间表明,抗胆碱能治疗导致认知灵活性缺陷。该提案的第二个目标是确定背内侧纹状体中特定的毒蕈碱受体亚型是否有助于行为灵活性。先前的研究发现,纹状体中的多巴胺活动也会影响认知灵活性。此外,现有的研究表明,多巴胺和胆碱能系统之间的相互作用,在基底神经节有关的运动行为。该提案的第三个目标是确定多巴胺D1和/或D2受体是否调节背内侧纹状体中的乙酰胆碱流出以影响行为灵活性。总的来说,这种方法在研究实际学习和策略转换过程中纹状体乙酰胆碱释放的动态变化方面采取了独特的方法。拟议的研究还将提供有关可能促进背内侧纹状体行为灵活性的特定毒蕈碱受体的补充信息。此外,拟议的研究可以帮助解开特定纹状体回路中神经递质的复杂相互作用,因为它与行为灵活性有关。这些实验的发现可能有助于开发选择性和靶向的药物干预,以减轻帕金森病和亨廷顿病的认知障碍,而不会产生不必要的运动副作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL E RAGOZZINO其他文献

MICHAEL E RAGOZZINO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL E RAGOZZINO', 18)}}的其他基金

Striatal Glutamate Signaling and Cognition in Autism Mouse Models
自闭症小鼠模型中的纹状体谷氨酸信号传导和认知
  • 批准号:
    9324297
  • 财政年份:
    2016
  • 资助金额:
    $ 18.27万
  • 项目类别:
Striatal Glutamate Signaling and Cognition in Autism Mouse Models
自闭症小鼠模型中的纹状体谷氨酸信号传导和认知
  • 批准号:
    9180311
  • 财政年份:
    2016
  • 资助金额:
    $ 18.27万
  • 项目类别:
Aging, Serotonin and Reversal Learning
衰老、血清素和逆转学习
  • 批准号:
    7474570
  • 财政年份:
    2007
  • 资助金额:
    $ 18.27万
  • 项目类别:
Aging, Serotonin and Reversal Learning
衰老、血清素和逆转学习
  • 批准号:
    7314504
  • 财政年份:
    2007
  • 资助金额:
    $ 18.27万
  • 项目类别:
Striatal Acetylcholine and Behavioral Flexibility
纹状体乙酰胆碱和行为灵活性
  • 批准号:
    6679037
  • 财政年份:
    2003
  • 资助金额:
    $ 18.27万
  • 项目类别:
Striatal Acetylcholine and Behavioral Flexibility
纹状体乙酰胆碱和行为灵活性
  • 批准号:
    6911589
  • 财政年份:
    2003
  • 资助金额:
    $ 18.27万
  • 项目类别:
STRIATAL CIRCUITRY AND BEHAVIORAL FLEXIBILITY
纹状体回路和行为灵活性
  • 批准号:
    6166891
  • 财政年份:
    2000
  • 资助金额:
    $ 18.27万
  • 项目类别:
MNEMONIC PROPERTIES OF THE PREFRONTAL CORTEX
前额叶皮层的记忆特性
  • 批准号:
    2890007
  • 财政年份:
    1999
  • 资助金额:
    $ 18.27万
  • 项目类别:
MNEMONIC PROPERTIES OF THE PREFRONTAL CORTEX
前额叶皮层的记忆特性
  • 批准号:
    2674569
  • 财政年份:
    1998
  • 资助金额:
    $ 18.27万
  • 项目类别:
MNEMONIC PROPERTIES OF THE PREFRONTAL CORTEX
前额叶皮层的记忆特性
  • 批准号:
    2413029
  • 财政年份:
    1998
  • 资助金额:
    $ 18.27万
  • 项目类别:

相似国自然基金

新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 批准年份:
    2010
  • 资助金额:
    26.0 万元
  • 项目类别:
    地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
  • 批准号:
    30960334
  • 批准年份:
    2009
  • 资助金额:
    22.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
  • 批准号:
    10657993
  • 财政年份:
    2023
  • 资助金额:
    $ 18.27万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10381163
  • 财政年份:
    2022
  • 资助金额:
    $ 18.27万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10531959
  • 财政年份:
    2022
  • 资助金额:
    $ 18.27万
  • 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
  • 批准号:
    10700991
  • 财政年份:
    2022
  • 资助金额:
    $ 18.27万
  • 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10518582
  • 财政年份:
    2022
  • 资助金额:
    $ 18.27万
  • 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
  • 批准号:
    10672973
  • 财政年份:
    2022
  • 资助金额:
    $ 18.27万
  • 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
  • 批准号:
    10585925
  • 财政年份:
    2022
  • 资助金额:
    $ 18.27万
  • 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
  • 批准号:
    10180000
  • 财政年份:
    2021
  • 资助金额:
    $ 18.27万
  • 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
  • 批准号:
    10049426
  • 财政年份:
    2021
  • 资助金额:
    $ 18.27万
  • 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
  • 批准号:
    10295809
  • 财政年份:
    2021
  • 资助金额:
    $ 18.27万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了